Nearly 12 million adults in the United States have been diagnosed with chronic obstructive pulmonary disease, with roughly 180,000 patients dying annually with end-stage refractory lung diseases. The only option currently available is lung transplantation, with high mortality rates due to the lack of donor organs. Current research is investing much time and resources into bioengineering strategies to regenerate lungs, however, to-date it has not … Continue reading Donor stem cells used to grow fully functioning lungs in live mice.